1. Luo, Hong-Yang, Mu, Wang-Jing, Chen, Min, Chen, Hu-Min, Guo, Liang. 2024. Hepatic Klf10-Fh1 axis promotes exercise-mediated amelioration of NASH in mice. In Metabolism: clinical and experimental, 155, 155916. doi:10.1016/j.metabol.2024.155916. https://pubmed.ncbi.nlm.nih.gov/38615945/
2. DiMario, Joseph X. 2018. KLF10 Gene Expression Modulates Fibrosis in Dystrophic Skeletal Muscle. In The American journal of pathology, 188, 1263-1275. doi:10.1016/j.ajpath.2018.01.014. https://pubmed.ncbi.nlm.nih.gov/29458012/
3. Elalfy, Mohsen S, El Sherif, Nayera H K, Kamal, Tarek M, Aly, Nihal H. . Klf10 Gene, a Secondary Modifier and a Pharmacogenomic Biomarker of Hydroxyurea Treatment Among Patients With Hemoglobinopathies. In Journal of pediatric hematology/oncology, 39, e155-e162. doi:10.1097/MPH.0000000000000762. https://pubmed.ncbi.nlm.nih.gov/28085748/
4. Dasgupta, Aneesha, Gibbard, Daniel F, Schmitt, Rebecca E, Jatoi, Aminah, Doles, Jason D. 2023. A TGF-β/KLF10 signaling axis regulates atrophy-associated genes to induce muscle wasting in pancreatic cancer. In Proceedings of the National Academy of Sciences of the United States of America, 120, e2215095120. doi:10.1073/pnas.2215095120. https://pubmed.ncbi.nlm.nih.gov/37585460/
5. Hwang, Soonjae, Park, Sangbin, Yaseen, Uzma, Lee, Ho-Jae, Cha, Ji-Young. 2023. KLF10 Inhibits TGF-β-Mediated Activation of Hepatic Stellate Cells via Suppression of ATF3 Expression. In International journal of molecular sciences, 24, . doi:10.3390/ijms241612602. https://pubmed.ncbi.nlm.nih.gov/37628783/
6. Lin, Yueh-Min, Yeh, Kun-Tu, Yeh, Chung-Min, Soon, Maw-Soan, Hsu, Li-Sung. 2022. KLF10 Functions as an Independent Prognosis Factor for Gastric Cancer. In Medicina (Kaunas, Lithuania), 58, . doi:10.3390/medicina58060711. https://pubmed.ncbi.nlm.nih.gov/35743973/
智鼠故事 
